|
|
ossification
|
GO:0001503 |
216 |
0.431
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.327
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.250
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.234
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.232
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.227
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.214
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.212
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.203
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.199
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.196
|
|
|
|
midbrain development
|
GO:0030901 |
35 |
0.195
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.184
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.182
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.169
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.163
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.159
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.159
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.153
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.152
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.149
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.147
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.145
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.142
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.141
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.141
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.139
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.135
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.133
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.132
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.132
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.131
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.130
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.128
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.124
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.112
|
|
|
|
cell fate commitment involved in formation of primary germ layer
|
GO:0060795 |
26 |
0.112
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.111
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.110
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.108
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.107
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.107
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.104
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.104
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.103
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.103
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.103
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.102
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.099
|
|
|
|
brain morphogenesis
|
GO:0048854 |
32 |
0.098
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.097
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.097
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.095
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.095
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.092
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.092
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.092
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.091
|
|
|
|
forebrain morphogenesis
|
GO:0048853 |
17 |
0.090
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.090
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.088
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.087
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.086
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.084
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.084
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.084
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.084
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.083
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.083
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.083
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.083
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.082
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.081
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.081
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.081
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.081
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.080
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.080
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.080
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.078
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.078
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.077
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.077
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.077
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.077
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.076
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.075
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.074
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.074
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.073
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.073
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.073
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.072
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.072
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.071
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.071
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.071
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.070
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.070
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.070
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.070
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.070
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.070
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.069
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.069
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.069
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.066
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.065
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.065
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.064
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.064
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.063
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.063
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.063
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.062
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.062
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.061
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.061
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.061
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.061
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.060
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.060
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.060
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.060
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.059
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.059
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.059
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.059
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.059
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.059
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.059
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.058
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.058
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.057
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.057
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.057
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.056
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.056
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.056
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.056
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.056
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.056
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.055
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.055
|
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.054
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.054
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.054
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.053
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.053
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.053
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.052
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.052
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.052
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.052
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.051
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.051
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.051
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.051
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.051
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.050
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.050
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.050
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.050
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.050
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.050
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.050
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.049
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.049
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.049
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.049
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.049
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.049
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.049
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.048
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.048
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.048
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.048
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.048
|
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072040 |
4 |
0.048
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.048
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.048
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.048
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.048
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.048
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.047
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.047
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.047
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.047
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.046
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.046
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.046
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.046
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.046
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.046
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.046
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.045
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.045
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.045
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.045
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.045
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.044
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.044
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.044
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.043
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.043
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.043
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.043
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.043
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.043
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.043
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.042
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.042
|
|
|
|
positive regulation of lens epithelial cell proliferation
|
GO:2001111 |
1 |
0.042
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.042
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.042
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.042
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.041
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.041
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.040
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.040
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.040
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.040
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.040
|
|
|
|
negative regulation of embryonic development
|
GO:0045992 |
22 |
0.040
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.039
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.039
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry
|
GO:1900094 |
2 |
0.039
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.039
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.039
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.039
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.039
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.039
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.039
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.039
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.039
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.039
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.039
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.038
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.038
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.037
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.037
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.037
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.037
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.037
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.037
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.037
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.037
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.037
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.036
|
|
|
|
regulation of urine volume
|
GO:0035809 |
6 |
0.036
|
|
|
|
bone trabecula morphogenesis
|
GO:0061430 |
12 |
0.036
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.036
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.035
|
|
|
|
mesodermal cell fate commitment
|
GO:0001710 |
17 |
0.035
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.035
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.035
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.035
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.035
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.035
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.034
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.034
|
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.034
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.034
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.034
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.034
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.034
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.034
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.034
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.033
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.033
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.033
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.033
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.033
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.033
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.033
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.033
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.033
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.033
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.033
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.033
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.033
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.032
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.032
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.032
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.032
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.032
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.032
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.031
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.031
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.031
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.031
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.031
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.031
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.031
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.031
|
|
|
|
nodal signaling pathway involved in determination of left right asymmetry
|
GO:0038107 |
2 |
0.031
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.031
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.031
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.031
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.031
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.031
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.031
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.030
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.030
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.030
|
|
|
|
axial mesodermal cell fate commitment
|
GO:0048322 |
1 |
0.030
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.030
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.030
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.030
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.030
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.030
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.029
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.029
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.029
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.029
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.029
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.029
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.029
|
|
|
|
axial mesoderm formation
|
GO:0048320 |
3 |
0.029
|
|
|
|
nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry
|
GO:1900164 |
2 |
0.029
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.029
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.029
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.029
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.029
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.029
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.029
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.029
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.029
|
|
|
|
left lung development
|
GO:0060459 |
4 |
0.028
|
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.028
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.028
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.028
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.028
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.028
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.028
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.028
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.028
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.028
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.028
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.028
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.028
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.028
|
|
|
|
transforming growth factor beta receptor signaling pathway involved in primitive streak formation
|
GO:0090010 |
1 |
0.027
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.027
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.027
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.027
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.027
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.027
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.027
|
|
|
|
metanephric nephron tubule formation
|
GO:0072289 |
4 |
0.027
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.027
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.027
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.027
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.027
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.027
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.027
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.026
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.026
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.026
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.026
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.026
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.026
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.026
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.026
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.026
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.026
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.025
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.025
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.025
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.025
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.025
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.025
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.025
|
|
|
|
spinal cord motor neuron differentiation
|
GO:0021522 |
35 |
0.025
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.025
|
|
|
|
segment specification
|
GO:0007379 |
15 |
0.025
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.025
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.025
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.025
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.024
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.024
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.024
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.024
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.024
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.024
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.024
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.024
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.024
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.024
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.024
|
|
|
|
positive regulation of skeletal muscle tissue regeneration
|
GO:0043415 |
4 |
0.024
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.024
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.024
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.024
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.024
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.024
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.024
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.024
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.024
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.024
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.024
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.023
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.023
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.023
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.023
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.023
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.023
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.023
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.023
|
|
|
|
diencephalon morphogenesis
|
GO:0048852 |
6 |
0.023
|
|
|
|
bone trabecula formation
|
GO:0060346 |
9 |
0.023
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.023
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.023
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.023
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.023
|
|
|
|
atrial cardiac muscle tissue development
|
GO:0003228 |
5 |
0.023
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.022
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.022
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.022
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.022
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072039 |
4 |
0.022
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.022
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.022
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
26 |
0.022
|
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
29 |
0.022
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.022
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.022
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.022
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.022
|
|
|
|
neurohypophysis development
|
GO:0021985 |
2 |
0.022
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.022
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.022
|
|
|
|
floor plate morphogenesis
|
GO:0033505 |
3 |
0.022
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.022
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.022
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.022
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.022
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.021
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.021
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.021
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.021
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.021
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.021
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.021
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.021
|
|
|
|
nodal signaling pathway
|
GO:0038092 |
10 |
0.021
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.021
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.021
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.021
|
|
|
|
detection of mechanical stimulus involved in equilibrioception
|
GO:0050973 |
2 |
0.021
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.021
|
|
|
|
atrial septum primum morphogenesis
|
GO:0003289 |
3 |
0.021
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.021
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.021
|
|
|
|
morphogenesis of an epithelial fold
|
GO:0060571 |
28 |
0.021
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.021
|
|
|
|
positive regulation of tendon cell differentiation
|
GO:2001051 |
1 |
0.020
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.020
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.020
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.020
|
|
|
|
negative regulation of stem cell maintenance
|
GO:1902455 |
4 |
0.020
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.020
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.020
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.020
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.020
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.020
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.020
|
|
|
|
positive regulation of chondrocyte differentiation
|
GO:0032332 |
13 |
0.020
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.020
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.020
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.020
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.020
|
|
|
|
cochlea morphogenesis
|
GO:0090103 |
22 |
0.020
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.020
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.020
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.020
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.020
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.020
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.020
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.020
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.020
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.020
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.020
|
|
|
|
cell surface receptor signaling pathway involved in heart development
|
GO:0061311 |
15 |
0.020
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.020
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.019
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.019
|
|
